secwatch.observer — SEC 8-K summary
======================================

Issuer:     CASTLE BIOSCIENCES INC (CSTL)
CIK:        0001447362
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001447362-23-000097
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Castle Biosciences reaffirms FY2023 revenue guidance of $170-180M and 2025 targets
--------------------------------------------------------------------------------

- Reaffirms FY2023 total revenue guidance of $170-$180M.
- Reaffirms 2025 total revenue target of $255-$330M.
- Reaffirms target to achieve net operating cash flow positivity by 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447362/000144736223000097/0001447362-23-000097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447362/000144736223000097/cstl-20230605.htm
  HTML page:      https://secwatch.observer/filing/0001447362-23-000097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer